| Ticker Details |
Sensus Healthcare, Inc. Common Stock
Sensus Healthcare Inc is a manufacturer of superficial radiation therapy devices. The Company's products and services include SRT-100, SRT-100 Vision, and Sentinel service program.
|
| IPO Date: |
July 25, 2016 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$52.51M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.16 | 2.93%
|
| Avg Daily Range (30 D): |
$0.08 | 2.16%
|
| Avg Daily Range (90 D): |
$0.11 | 2.61%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.12M |
| Avg Daily Volume (30 D): |
.06M |
| Avg Daily Volume (90 D): |
.08M |
| Trade Size |
| Avg Trade Size (Sh.): |
145 |
| Avg Trade Size (Sh.) (30 D): |
153 |
| Avg Trade Size (Sh.) (90 D): |
141 |
| Institutional Trades |
| Total Institutional Trades: |
7 |
| Avg Institutional Trade: |
$.74M |
| Avg Institutional Trade (30 D): |
$M |
| Avg Institutional Trade (90 D): |
$M |
| Avg Institutional Trade Volume: |
.09M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$.6M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
78.95K |
|
|
| News |
Oct 9, 2025 @ 5:00 PM
MAREX REMINDER: Bragar Eagel & Squire, P.C. Remind...
Source: Bragar Eagel & Squire, P.C.
|
Oct 9, 2025 @ 4:58 PM
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squi...
Source: Bragar Eagel & Squire, P.C.
|
Oct 9, 2025 @ 4:49 PM
AVITA REMINDER: Bragar Eagel & Squire, P.C. Remind...
Source: Bragar Eagel & Squire, P.C.
|
Aug 31, 2025 @ 12:13 PM
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Inves...
Source: Bragar Eagel & Squire, P.C.
|
Aug 28, 2025 @ 7:43 PM
Sensus Healthcare, Inc. Investors: Company Investi...
Source: Lesley F. Portnoy
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.47
|
$-.16
|
$-.19
|
|
Diluted EPS
|
$-.47
|
$-.16
|
$-.19
|
|
Revenue
|
$22.53M
|
$3.39M
|
$4.94M
|
|
Gross Profit
|
$8.5M
|
$.99M
|
$1.9M
|
|
Net Income / Loss
|
$-7.77M
|
$-2.63M
|
$-3.17M
|
|
Operating Income / Loss
|
$-12.02M
|
$-4.36M
|
$-3.15M
|
|
Cost of Revenue
|
$14.03M
|
$2.4M
|
$3.04M
|
|
Net Cash Flow
|
$.03M
|
$M
|
$-2.37M
|
|
PE Ratio
|
|
|
|
|
|
|